| Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis (NCT04976140) | Paean Biotechnology Inc. | 2021-12-15 |
| Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM) (NCT04723303) | University of Florida | 2021-10-06 |
| Add-on Intravenous Immunoglobulins in Early Myositis (NCT05832034) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2021-09-13 |
| Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties (NCT05027152) | Federal University of Espirito Santo | 2021-09-01 |
| High-intensity Strength Training in Myositis (NCT04486261) | Rigshospitalet, Denmark | 2021-08-30 |
| Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM. (NCT04628936) | Kezar Life Sciences, Inc. | 2020-11-04 |
| Rheumatology Patient Registry and Biorepository (NCT04402086) | Yale University | 2020-08-04 |
| A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis (NCT04033926) | Kezar Life Sciences, Inc. | 2020-01-14 |
| A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis (NCT03817424) | Amgen | 2018-12-13 |
| Predictor of Clinical Response to Acthar in Myositis (NCT03414086) | University of Pittsburgh | 2017-11-06 |
| Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and Dermatomyositis (NCT03324152) | Karolinska University Hospital | 2017-10-01 |
| Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy (NCT02971683) | Bristol-Myers Squibb | 2017-05-04 |
| Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis (NCT02043548) | Chester Oddis | 2014-10-01 |
| Study of the Prevalence of Polymyositis and Dermatomyositis in Normandy (NCT02880527) | University Hospital, Rouen | 2014-07-01 |
| Acthar in Treatment of Refractory Dermatomyositis and Polymyositis (NCT01906372) | Rohit Aggarwal, MD | 2013-09-01 |
| Efficacy and Tolerability of BAF312 in Patients With Polymyositis (NCT01801917) | Novartis Pharmaceuticals | 2013-04-24 |
| Dermatomyositis and Polymyositis Registry (NCT01637064) | Phoenix Neurological Associates, LTD | 2013-04-01 |
| Epidemiological Study of Inflammatory Myopathies in a French Region (NCT02881450) | University Hospital, Strasbourg, France | 2012-01-01 |
| Abatacept Treatment in Polymyositis and Dermatomyositis (NCT01315938) | Karolinska Institutet | 2011-01-01 |
| Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies (NCT01432613) | Assistance Publique - Hôpitaux de Paris | 2010-12-22 |
| Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis (NCT01813617) | Karolinska University Hospital | 2010-09-01 |
| Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis (NCT01148810) | Novartis Pharmaceuticals | 2010-06-15 |
| Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM (NCT00651040) | Institute of Rheumatology, Prague | 2008-05-01 |
| Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis (NCT01415219) | University Hospital, Lille | 2008-03-01 |
| Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM) (NCT00335985) | Japan Blood Products Organization | 2006-06-01 |
| Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) (NCT00106184) | University of Pittsburgh | 2006-03-01 |
| myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies (NCT00213629) | University Hospital, Rouen | 2004-11-01 |
| Anakinra in Myositis (NCT01165008) | Karolinska Institutet | 2003-09-01 |
| Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis (NCT00033891) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2002-04-10 |
| Hand Function in Patients With Poly- or Dermatomyositis (NCT00866125) | Karolinska Institutet | 2002-04-01 |
| Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol. (NCT00138983) | UMC Utrecht | 2000-05-01 |
| Adult and Juvenile Myositis (NCT00017914) | National Institute of Environmental Health Sciences (NIEHS) | 1995-06-07 |
| Methimazole to Treat Polymyositis and Dermatomyositis (NCT00001421) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1995-06-01 |
| Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity (NCT03941184) | Mayo Clinic | 1995-01-01 |
| Genetic and Family Studies of Inherited Muscle Diseases (NCT00001331) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1993-05-01 |
| Study and Treatment of Inflammatory Muscle Diseases (NCT00001265) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1992-01-10 |
| Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies (NCT00001261) | National Institute of Neurological Disorders and Stroke (NINDS) | 1990-05-01 |
| Ultrasound Evaluation of Tongue Movements in Speech and Swallowing (NCT00001167) | National Institutes of Health Clinical Center (CC) | 1979-08-01 |